Search results for:
2022 PPR 2022
Poster
Monday July 4
THE EFFECT OF PROBIOTICS ON FUNCTIONAL CONSTIPATION IN THE ELDERLY (PM-14)
A community pharmacy-led deprescribing service – in collaboration with general practice (GP) (PM-01)
Building bridges between community pharmacy and psychosocial care: findings from a Flemish pilot project (CAVAsa) (PM-22)
Comprehensibility of pharmaceutical pictograms in patient population in Albania (PM-21)
Documentation of clinical activities in community pharmacy using the ClinPhADoc tool: preliminary results (PM-05)
Drug-related problems experienced by patients with rheumatic diseases: A longitudinal observational study (PM-17)
Evaluation of a home-based service for medication review in Swiss community pharmacies: a study protocol (PM-13)
Evaluation of the prescription pattern and appropriateness of therapy in the management of bacterial STIs in three hospitals in Southern Ghana. (PM-23)
Exploring The Current State of Retail Clinics in Community Pharmacy Practice: A Preliminary Qualitative Study Among Pharmacists in Twenty-One Countries (PM-24)
Factors influencing patients' preferences for telehealth applications in rheumatic diseases: a qualitative study (PM-18)
Future directions regarding the implementation of pharmaceutical services in Romania- legislative changes and activities performed during the COVID-19 pandemic (PM-06)
Health literacy and self-care among Malaysian with type 2 diabetes: patients’ and pharmacists’ perspectives (PM-02)
Healthcare providers’ knowledge and awareness of deprescribing (PM-08)
Impact of COVID-19 on frontline pharmacists’ roles and services around the world: the INSPIRE Worldwide Survey (PM-03)
Implementing interventions in health care – how do we MAKE-IT work? (PM-30)
Interprofessional Collaboration (IPC): A Comparative Analysis of Global Standards for Pharmacy Practice (PM-10)
Linking implementation factors and targeted strategies for optimal implementation of community pharmacy services (PM-16)
MaPP(s)ing the Medication Journey: Supporting Patients with Changes at Discharge (PM-09)
Medication adherence evaluated through electronic monitors during the COVID-19 pandemic lockdown in Switzerland (PM-07)
One Recipe At A Time: Evaluating An Innovative Teaching Kitchen To Create Positive Health Outcomes (PM-19)
Patients' and healthcare providers' views on dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia: a qualitative study (PM-12)
Patients’ perspective on the development of a prescription opioid use disorder (PM-11)
Patients’ referral through a Minor Ailment Service in community pharmacy (PM-04)
Perspectives of Pharmaceutical Science Faculty in Promoting Pharmacy Research in Doctoral Students (PM-25)
Therapy-related determinants of medication non-adherence: a systematic review protocol. (PM-15)
Trimethoprim-sulfamethoxazole associated neutropenia in Mexican HIV patients: a cohort study (PM-28)
Understanding knowledge skills and attitude of pharmacists towards oral calcium supplements (PM-29)
Tuesday July 5
“CANNABIS FOR MEDICINAL USE IN PATIENTS WITH RARE DISEASES” (PT-11)
A collaborative practice program involving Community Pharmacies and Primary Care for COVID-19 detection (PT-06)
Chronic patients perceive conflicting information on their medications: in-depth qualitative interviews (PT-15)
Critical appraisal of dyslipidaemia clinical practice guidelines: a scoping review (PT-20)
Definitions and indexing of ‘simulated patient’ studies in health: a classification system proposal (PT-19)
Developing a questionnaire comprising clinically useful patient-reported outcome measures in software-assisted medication reviews (PT-05)
Discrepancies and changes during the initial medication review in the programme ARMIN: What do pharmacists and physicians contribute? (PT-18)
Do we understand online information given by healthcare providers during the COVID-19 pandemic? (PT-02)
EvaPharMed – Development and evaluation of an interprofessional education project for pharmacy and medical students: a pilot study (PT-13)
Feasibility of personalising dispensing quantities to prevent waste of oral anticancer drugs (PT-17)
Feasibility of the ‘Respiratory Adherence Care Enhancer’ (RACE) instrument supporting self-management by community pharmacists in asthma/COPD patients with maintenance inhaler therapy (PT-24)
Feasibility pilot study and potential impact of a mobile app intervention led by pharmacist, to support and improve self-management of diabetes, in Cyprus (PT-12)
Financing Prostate Cancer Therapy in the Ashanti Region of Ghana: What are the Financial Implications on Patients and Caregivers? (PT-25)
Impact of an intervention associating the community pharmacist and the use of a mobile health application for patients with type 2 diabetes (PT-03)
Knowledge, perception, and management of diabetes mellitus by traditional practitioners: A descriptive survey from Mifi division, Cameroon (PT-04)
On TRACk – Through Training, Preparation, and Counseling, to Better use of Inhaled Medication (PT-22)
Perceived Barriers and Facilitators to Community Pharmacy-based Tuberculosis Service in Malaysia (PT-26)
Potential Cost of Not Vaccinating against COVID-19 in the US (PT-16)
Quantifying problematic prescribing cascades (PT-07)
Search engine redirection convert patients to illegal online drug distribution websites (PT-10)
Search engine redirection convert patients to illegal online drug distribution websites (PT-10)
Telehealth Education and Music Therapy for Nursing-Home Residents during COVID-19 (PT-23)
The development and validation of a tool for measuring collaborative practice between community pharmacists and physicians from the perspective of the pharmacist: The Professional Collaborative Practice Tool (PCPT) (PT-14)
Towards a quality assurance system for medication reviews in German community pharmacies (PT-01)
Virtual Online Focus Group Discussions using Four Domains of Appreciative Inquiry to Explore Community Pharmacists' Actual Experiences and Aspirations around Antibiotic Smart Use in Thailand – a Qualitative Study (PT-09)